EKF Diagnostics Holdings PLC New orders for COVID-19 sample collection kits
October 22 2020 - 1:00AM
RNS Non-Regulatory
TIDMEKF
EKF Diagnostics Holdings PLC
22 October 2020
EKF Diagnostics Holdings plc
("EKF", the "Company" or the "Group")
New supply orders for COVID-19 sample collection kits
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed
point-of-care business, announces that it has received initial
orders for PrimeStore MTM COVID-19 sample collection devices from
two new customers, the Health Service Executive ("HSE"), Ireland
and a national health body in England. These orders will be
fulfilled from EKF's production facilities in Penarth, South Wales
and Barleben, Germany.
These orders will contribute to the expected strong Q4
performance and the Company intends to provide a further update on
trading in early November.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-executive Chairman Tel: +44 (0) 29 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer Tel: 020 7496 3000
Aubrey Powell / George Tzimas (Corporate
Finance)
Tom Salvesen (Corporate Broking)
Walbrook PR Limited Tel: +44 (0) 20 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: +44 (0) 7980 541 893 / +44 (0) 7584
391 303
About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com
)
EKF is a leading point-of-care diagnostics and central
laboratory assay manufacturer with an estimated 80,000 hemoglobin,
hematocrit, HbA1c, glucose and lactate analyzers in regular use
across more than 100 countries. EKF specializes in developing tests
for use in anemia and diabetes diagnosis and management, as well as
providing a portfolio of reagents for use in clinical chemistry
analyzers.
About PrimeStore MTM
The PrimeStore MTM sample collection device, deactivates
viruses, bacteria, fungi and mycobacterium tuberculosis allowing
safe sample handling and transport, greatly reducing risk of
infection. The device was invented by Longhorn Vaccines and
Diagnostics LLC ("Longhorn") in the US, in 2006 in preparation for
a worldwide pandemic and is designed to de-activate pathogen
rapidly and stabilise the RNA for up to four weeks with no
requirement for cold storage. In the case of COVID-19, by
deactivating the virus testing can now take place outside of
containment facilities opening up capacity in more testing
laboratories. With the flu season approaching, the PrimeStore MTM
can also safely collect flu and COVID-19 samples in the same
collection kit.
PrimeStore MTM was successfully evaluated for effective
SARS-CoV-2 inactivation in a study published by PHE. The study
showed that of the few transport reagents, from the 23 tested,
where no residual virus was detectable, PrimeStore MTM is the only
commercially available CE-marked and FDA cleared transport media.
EKF is a contract manufacturer for the PrimeStore MTM sample
collection device.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABRBDGGXDDGGB
(END) Dow Jones Newswires
October 22, 2020 02:00 ET (06:00 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024
